1 Anticancer Drugs Market Overview 1.1 Anticancer Drugs Product Overview 1.2 Anticancer Drugs Market Segment by Type 1.2.1 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) 1.2.2 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) 1.2.3 Hormonal Drugs 1.3 Global Anticancer Drugs Market Size by Type 1.3.1 Global Anticancer Drugs Market Size Overview by Type (2016-2027) 1.3.2 Global Anticancer Drugs Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Anticancer Drugs Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Anticancer Drugs Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Anticancer Drugs Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Anticancer Drugs Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Anticancer Drugs Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Anticancer Drugs Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Anticancer Drugs Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Anticancer Drugs Sales Breakdown by Type (2016-2021) 1.4.2 Europe Anticancer Drugs Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Anticancer Drugs Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Anticancer Drugs Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Anticancer Drugs Sales Breakdown by Type (2016-2021) 2 Global Anticancer Drugs Market Competition by Company 2.1 Global Top Players by Anticancer Drugs Sales (2016-2021) 2.2 Global Top Players by Anticancer Drugs Revenue (2016-2021) 2.3 Global Top Players Anticancer Drugs Price (2016-2021) 2.4 Global Top Manufacturers Anticancer Drugs Manufacturing Base Distribution, Sales Area, Product Type 2.5 Anticancer Drugs Market Competitive Situation and Trends 2.5.1 Anticancer Drugs Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Anticancer Drugs Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticancer Drugs as of 2020) 2.7 Date of Key Manufacturers Enter into Anticancer Drugs Market 2.8 Key Manufacturers Anticancer Drugs Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Anticancer Drugs Status and Outlook by Region 3.1 Global Anticancer Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Anticancer Drugs Historic Market Size by Region 3.2.1 Global Anticancer Drugs Sales in Volume by Region (2016-2021) 3.2.2 Global Anticancer Drugs Sales in Value by Region (2016-2021) 3.2.3 Global Anticancer Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Anticancer Drugs Forecasted Market Size by Region 3.3.1 Global Anticancer Drugs Sales in Volume by Region (2022-2027) 3.3.2 Global Anticancer Drugs Sales in Value by Region (2022-2027) 3.3.3 Global Anticancer Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Anticancer Drugs by Application 4.1 Anticancer Drugs Market Segment by Application 4.1.1 Lung Cancer 4.1.2 Breast Cancer 4.1.3 Leukemia 4.1.4 Colorectal Cancer 4.1.5 Other 4.2 Global Anticancer Drugs Market Size by Application 4.2.1 Global Anticancer Drugs Market Size Overview by Application (2016-2027) 4.2.2 Global Anticancer Drugs Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Anticancer Drugs Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Anticancer Drugs Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Anticancer Drugs Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Anticancer Drugs Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Anticancer Drugs Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Anticancer Drugs Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Anticancer Drugs Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Anticancer Drugs Sales Breakdown by Application (2016-2021) 4.3.2 Europe Anticancer Drugs Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Anticancer Drugs Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Anticancer Drugs Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Anticancer Drugs Sales Breakdown by Application (2016-2021) 5 North America Anticancer Drugs by Country 5.1 North America Anticancer Drugs Historic Market Size by Country 5.1.1 North America Anticancer Drugs Sales in Volume by Country (2016-2021) 5.1.2 North America Anticancer Drugs Sales in Value by Country (2016-2021) 5.2 North America Anticancer Drugs Forecasted Market Size by Country 5.2.1 North America Anticancer Drugs Sales in Volume by Country (2022-2027) 5.2.2 North America Anticancer Drugs Sales in Value by Country (2022-2027) 6 Europe Anticancer Drugs by Country 6.1 Europe Anticancer Drugs Historic Market Size by Country 6.1.1 Europe Anticancer Drugs Sales in Volume by Country (2016-2021) 6.1.2 Europe Anticancer Drugs Sales in Value by Country (2016-2021) 6.2 Europe Anticancer Drugs Forecasted Market Size by Country 6.2.1 Europe Anticancer Drugs Sales in Volume by Country (2022-2027) 6.2.2 Europe Anticancer Drugs Sales in Value by Country (2022-2027) 7 Asia-Pacific Anticancer Drugs by Region 7.1 Asia-Pacific Anticancer Drugs Historic Market Size by Region 7.1.1 Asia-Pacific Anticancer Drugs Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Anticancer Drugs Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Anticancer Drugs Forecasted Market Size by Region 7.2.1 Asia-Pacific Anticancer Drugs Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Anticancer Drugs Sales in Value by Region (2022-2027) 8 Latin America Anticancer Drugs by Country 8.1 Latin America Anticancer Drugs Historic Market Size by Country 8.1.1 Latin America Anticancer Drugs Sales in Volume by Country (2016-2021) 8.1.2 Latin America Anticancer Drugs Sales in Value by Country (2016-2021) 8.2 Latin America Anticancer Drugs Forecasted Market Size by Country 8.2.1 Latin America Anticancer Drugs Sales in Volume by Country (2022-2027) 8.2.2 Latin America Anticancer Drugs Sales in Value by Country (2022-2027) 9 Middle East and Africa Anticancer Drugs by Country 9.1 Middle East and Africa Anticancer Drugs Historic Market Size by Country 9.1.1 Middle East and Africa Anticancer Drugs Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Anticancer Drugs Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Anticancer Drugs Forecasted Market Size by Country 9.2.1 Middle East and Africa Anticancer Drugs Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Anticancer Drugs Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Anticancer Drugs Business 10.1 F. Hoffmann-La Roche Ltd 10.1.1 F. Hoffmann-La Roche Ltd Corporation Information 10.1.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview 10.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.1.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Products Offered 10.1.5 F. Hoffmann-La Roche Ltd Recent Development 10.2 Eli Lilly and Company 10.2.1 Eli Lilly and Company Corporation Information 10.2.2 Eli Lilly and Company Introduction and Business Overview 10.2.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.2.4 F. Hoffmann-La Roche Ltd Anticancer Drugs Products Offered 10.2.5 Eli Lilly and Company Recent Development 10.3 CELGENE CORPORATION 10.3.1 CELGENE CORPORATION Corporation Information 10.3.2 CELGENE CORPORATION Introduction and Business Overview 10.3.3 CELGENE CORPORATION Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.3.4 CELGENE CORPORATION Anticancer Drugs Products Offered 10.3.5 CELGENE CORPORATION Recent Development 10.4 Novartis AG 10.4.1 Novartis AG Corporation Information 10.4.2 Novartis AG Introduction and Business Overview 10.4.3 Novartis AG Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Novartis AG Anticancer Drugs Products Offered 10.4.5 Novartis AG Recent Development 10.5 Pfizer Inc 10.5.1 Pfizer Inc Corporation Information 10.5.2 Pfizer Inc Introduction and Business Overview 10.5.3 Pfizer Inc Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Pfizer Inc Anticancer Drugs Products Offered 10.5.5 Pfizer Inc Recent Development 10.6 Amgen Inc 10.6.1 Amgen Inc Corporation Information 10.6.2 Amgen Inc Introduction and Business Overview 10.6.3 Amgen Inc Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Amgen Inc Anticancer Drugs Products Offered 10.6.5 Amgen Inc Recent Development 10.7 Bayer AG 10.7.1 Bayer AG Corporation Information 10.7.2 Bayer AG Introduction and Business Overview 10.7.3 Bayer AG Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Bayer AG Anticancer Drugs Products Offered 10.7.5 Bayer AG Recent Development 10.8 AstraZeneca 10.8.1 AstraZeneca Corporation Information 10.8.2 AstraZeneca Introduction and Business Overview 10.8.3 AstraZeneca Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.8.4 AstraZeneca Anticancer Drugs Products Offered 10.8.5 AstraZeneca Recent Development 10.9 Takeda Pharmaceutical Company Limited 10.9.1 Takeda Pharmaceutical Company Limited Corporation Information 10.9.2 Takeda Pharmaceutical Company Limited Introduction and Business Overview 10.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Takeda Pharmaceutical Company Limited Anticancer Drugs Products Offered 10.9.5 Takeda Pharmaceutical Company Limited Recent Development 10.10 Merck & Co. 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Anticancer Drugs Product Category, Application and Specification 10.10.3 Merck & Co. Anticancer Drugs Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 Merck & Co. Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Anticancer Drugs Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Anticancer Drugs Industrial Chain Analysis 11.4 Anticancer Drugs Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Anticancer Drugs Distributors 12.3 Anticancer Drugs Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) Table 2. Major Company of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) Table 3. Major Company of Hormonal Drugs Table 4. Global Anticancer Drugs Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Anticancer Drugs Sales by Type (2016-2021) & (MT) Table 6. Global Anticancer Drugs Sales Market Share in Volume by Type (2016-2021) Table 7. Global Anticancer Drugs Sales by Type (2016-2021) & (US& Million) Table 8. Global Anticancer Drugs Market Share in Value by Type (2016-2021) Table 9. Global Anticancer Drugs Price by Type (2016-2021) & (USD/Kg) Table 10. Global Anticancer Drugs Sales by Type (2022-2027) & (MT) Table 11. Global Anticancer Drugs Sales Market Share in Volume by Type (2022-2027) Table 12. Global Anticancer Drugs Sales by Type (2022-2027) & (US$ Million) Table 13. Global Anticancer Drugs Sales Market Share in Value by Type (2022-2027) Table 14. Global Anticancer Drugs Price by Type (2022-2027) & (USD/Kg) Table 15. North America Anticancer Drugs Sales by Type (2016-2021) & (MT) Table 16. North America Anticancer Drugs Sales by Type (2016-2021) & (US$ Million) Table 17. Europe Anticancer Drugs Sales (MT) by Type (2016-2021) Table 18. Europe Anticancer Drugs Sales by Type (2016-2021) & (US$ Million) Table 19. Asia-Pacific Anticancer Drugs Sales (MT) by Type (2016-2021) Table 20. Asia-Pacific Anticancer Drugs Sales by Type (2016-2021) & (US$ Million) Table 21. Latin America Anticancer Drugs Sales (MT) by Type (2016-2021) Table 22. Latin America Anticancer Drugs Sales by Type (2016-2021) & (US$ Million) Table 23. Middle East and Africa Anticancer Drugs Sales (MT) by Type (2016-2021) Table 24. Middle East and Africa Anticancer Drugs Sales by Type (2016-2021) & (US$ Million) Table 25. Global Anticancer Drugs Sales by Company (2016-2021) & (MT) Table 26. Global Anticancer Drugs Sales Share by Company (2016-2021) Table 27. Global Anticancer Drugs Revenue by Company (2016-2021) & (US$ Million) Table 28. Global Anticancer Drugs Revenue Share by Company (2016-2021) Table 29. Global Market Anticancer Drugs Price by Company (2016-2021) & (USD/Kg) Table 30. Global Anticancer Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area Table 31. Global Anticancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticancer Drugs as of 2020 Table 33. Date of Key Manufacturers Enter into Anticancer Drugs Market Table 34. Key Manufacturers Anticancer Drugs Product Type Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Anticancer Drugs Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 37. Global Anticancer Drugs Sales by Region (2016-2021) & (MT) Table 38. Global Anticancer Drugs Sales Market Share in Volume by Region (2016-2021) Table 39. Global Anticancer Drugs Sales by Region (2016-2021) & (US$ Million) Table 40. Global Anticancer Drugs Sales Market Share in Value by Region (2016-2021) Table 41. Global Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 42. Global Anticancer Drugs Sales by Region (2022-2027) & (MT) Table 43. Global Anticancer Drugs Sales Market Share in Volume by Region (2022-2027) Table 44. Global Anticancer Drugs Sales by Region (2022-2027) & (US$ Million) Table 45. Global Anticancer Drugs Sales Market Share in Value by Region (2022-2027) Table 46. Global Anticancer Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2022-2027) Table 47. Global Anticancer Drugs Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 48. Global Anticancer Drugs Sales by Application (2016-2021) & (MT) Table 49. Global Anticancer Drugs Sales Market Share in Volume by Application (2016-2021) Table 50. Global Anticancer Drugs Sales by Application (2016-2021) & (US$ Million) Table 51. Global Anticancer Drugs Sales Market Share in Value by Application (2016-2021) Table 52. Global Anticancer Drugs Price by Application (2016-2021) & (USD/Kg) Table 53. Global Anticancer Drugs Sales by Application (2022-2027) & (MT) Table 54. Global Anticancer Drugs Sales Market Share in Volume by Application (2022-2027) Table 55. Global Anticancer Drugs Sales by Application (2022-2027) & (US$ Million) Table 56. Global Anticancer Drugs Sales Market Share in Value by Application (2022-2027) Table 57. Global Anticancer Drugs Price by Application (2022-2027) & (USD/Kg) Table 58. North America Anticancer Drugs Sales by Application (2016-2021) (MT) Table 59. North America Anticancer Drugs Sales by Application (2016-2021) & (US$ Million) Table 60. North America Anticancer Drugs Sales Market Share in Value by Application in 2020 Table 61. Europe Anticancer Drugs Sales by Application (2016-2021) (MT) Table 62. Europe Anticancer Drugs Sales by Application (2016-2021) & (US$ Million) Table 63. Europe Anticancer Drugs Sales Market Share in Value by Application in 2020 Table 64. Asia-Pacific Anticancer Drugs Sales by Application (2016-2021) (MT) Table 65. Asia-Pacific Anticancer Drugs Sales by Application (2016-2021) & (US$ Million) Table 66. Asia-Pacific Anticancer Drugs Sales Market Share in Value by Application in 2020 Table 67. Latin America Anticancer Drugs Sales by Application (2016-2021) (MT) Table 68. Latin America Anticancer Drugs Sales by Application (2016-2021) & (US$ Million) Table 69. Latin America Anticancer Drugs Sales Market Share in Value by Application in 2020 Table 70. Middle East and Africa Anticancer Drugs Sales by Application (2016-2021) (MT) Table 71. Middle East and Africa Anticancer Drugs Sales by Application (2016-2021) & (US$ Million) Table 72. Middle East and Africa Anticancer Drugs Sales Market Share in Value by Application in 2020 Table 73. North America Anticancer Drugs Sales by Country (2016-2021) & (MT) Table 74. North America Anticancer Drugs Sales Market Share in Volume by Country (2016-2021) Table 75. North America Anticancer Drugs Sales by Country (2016-2021) & (US$ Million) Table 76. North America Anticancer Drugs Sales Market Share in Value by Country (2016-2021) Table 77. North America Anticancer Drugs Sales by Country (2022-2027) & (MT) Table 78. North America Anticancer Drugs Sales Market Share in Volume by Country (2022-2027) Table 79. North America Anticancer Drugs Sales by Country (2022-2027) & (US$ Million) Table 80. North America Anticancer Drugs Sales Market Share in Value by Country (2022-2027) Table 81. Europe Anticancer Drugs Sales by Country (2016-2021) & (MT) Table 82. Europe Anticancer Drugs Sales Market Share in Volume by Country (2016-2021) Table 83. Europe Anticancer Drugs Sales by Country (2016-2021) & (US$ Million) Table 84. Europe Anticancer Drugs Sales Market Share in Value by Country (2016-2021) Table 85. Europe Anticancer Drugs Sales by Country (2022-2027) & (MT) Table 86. Europe Anticancer Drugs Sales Market Share in Volume by Country (2022-2027) Table 87. Europe Anticancer Drugs Sales by Country (2022-2027) & (US$ Million) Table 88. Europe Anticancer Drugs Sales Market Share in Value by Country (2022-2027) Table 89. Asia-Pacific Anticancer Drugs Sales by Region (2016-2021) & (MT) Table 90. Asia-Pacific Anticancer Drugs Sales Market Share in Volume by Region (2016-2021) Table 91. Asia-Pacific Anticancer Drugs Sales by Region (2016-2021) & (US$ Million) Table 92. Asia-Pacific Anticancer Drugs Sales Market Share in Value by Region (2016-2021) Table 93. Asia-Pacific Anticancer Drugs Sales by Region (2022-2027) & (MT) Table 94. Asia-Pacific Anticancer Drugs Sales Market Share in Volume by Region (2022-2027) Table 95. Asia-Pacific Anticancer Drugs Sales by Region (2022-2027) & (US$ Million) Table 96. Asia-Pacific Anticancer Drugs Sales Market Share in Value by Region (2022-2027) Table 97. Latin America Anticancer Drugs Sales by Country (2016-2021) & (MT) Table 98. Latin America Anticancer Drugs Sales Market Share in Volume by Country (2016-2021) Table 99. Latin America Anticancer Drugs Sales by Country (2016-2021) & (US$ Million) Table 100. Latin America Anticancer Drugs Sales Market Share in Value by Country (2016-2021) Table 101. Latin America Anticancer Drugs Sales by Country (2022-2027) & (MT) Table 102. Latin America Anticancer Drugs Sales Market Share in Volume by Country (2022-2027) Table 103. Latin America Anticancer Drugs Sales by Country (2022-2027) & (US$ Million) Table 104. Latin America Anticancer Drugs Sales Market Share in Value by Country (2022-2027) Table 105. Middle East and Africa Anticancer Drugs Sales by Country (2016-2021) & (MT) Table 106. Middle East and Africa Anticancer Drugs Sales Market Share in Volume by Country (2016-2021) Table 107. Middle East and Africa Anticancer Drugs Sales by Country (2016-2021) & (US$ Million) Table 108. Middle East and Africa Anticancer Drugs Sales Market Share in Value by Country (2016-2021) Table 109. Middle East and Africa Anticancer Drugs Sales by Country (2022-2027) & (MT) Table 110. Middle East and Africa Anticancer Drugs Sales Market Share in Volume by Country (2022-2027) Table 111. Middle East and Africa Anticancer Drugs Sales by Country (2022-2027) & (US$ Million) Table 112. Middle East and Africa Anticancer Drugs Sales Market Share in Value by Country (2022-2027) Table 113. F. Hoffmann-La Roche Ltd Corporation Information Table 114. F. Hoffmann-La Roche Ltd Introduction and Business Overview Table 115. F. Hoffmann-La Roche Ltd Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 116. F. Hoffmann-La Roche Ltd Anticancer Drugs Product Table 117. F. Hoffmann-La Roche Ltd Recent Development Table 118. Eli Lilly and Company Corporation Information Table 119. Eli Lilly and Company Introduction and Business Overview Table 120. Eli Lilly and Company Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 121. Eli Lilly and Company Anticancer Drugs Product Table 122. Eli Lilly and Company Recent Development Table 123. CELGENE CORPORATION Corporation Information Table 124. CELGENE CORPORATION Introduction and Business Overview Table 125. CELGENE CORPORATION Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 126. CELGENE CORPORATION Anticancer Drugs Product Table 127. CELGENE CORPORATION Recent Development Table 128. Novartis AG Corporation Information Table 129. Novartis AG Introduction and Business Overview Table 130. Novartis AG Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 131. Novartis AG Anticancer Drugs Product Table 132. Novartis AG Recent Development Table 133. Pfizer Inc Corporation Information Table 134. Pfizer Inc Introduction and Business Overview Table 135. Pfizer Inc Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 136. Pfizer Inc Anticancer Drugs Product Table 137. Pfizer Inc Recent Development Table 138. Amgen Inc Corporation Information Table 139. Amgen Inc Introduction and Business Overview Table 140. Amgen Inc Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 141. Amgen Inc Anticancer Drugs Product Table 142. Amgen Inc Recent Development Table 143. Bayer AG Corporation Information Table 144. Bayer AG Introduction and Business Overview Table 145. Bayer AG Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 146. Bayer AG Anticancer Drugs Product Table 147. Bayer AG Recent Development Table 148. AstraZeneca Corporation Information Table 149. AstraZeneca Introduction and Business Overview Table 150. AstraZeneca Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 151. AstraZeneca Anticancer Drugs Product Table 152. AstraZeneca Recent Development Table 153. Takeda Pharmaceutical Company Limited Corporation Information Table 154. Takeda Pharmaceutical Company Limited Introduction and Business Overview Table 155. Takeda Pharmaceutical Company Limited Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 156. Takeda Pharmaceutical Company Limited Anticancer Drugs Product Table 157. Takeda Pharmaceutical Company Limited Recent Development Table 158. Merck & Co. Corporation Information Table 159. Merck & Co. Introduction and Business Overview Table 160. Merck & Co. Anticancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021) Table 161. Merck & Co. Anticancer Drugs Product Table 162. Merck & Co. Recent Development Table 163. Key Raw Materials Lists Table 164. Raw Materials Key Suppliers Lists Table 165. Anticancer Drugs Market Trends Table 166. Anticancer Drugs Market Drivers Table 167. Anticancer Drugs Market Challenges Table 168. Anticancer Drugs Market Restraints Table 169. Anticancer Drugs Distributors List Table 170. Anticancer Drugs Downstream Customers Table 171. Research Programs/Design for This Report Table 172. Key Data Information from Secondary Sources Table 173. Key Data Information from Primary Sources List of Figures Figure 1. Anticancer Drugs Product Picture Figure 2. Global Anticancer Drugs Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Anticancer Drugs Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Anticancer Drugs Sales Status and Outlook (2016-2027) & (MT) Figure 5. Product Picture of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) Figure 6. Global Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) Sales YoY Growth (2016-2021) & (MT) Figure 7. Product Picture of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) Figure 8. Global Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) Sales YoY Growth (2016-2021) & (MT) Figure 9. Product Picture of Hormonal Drugs Figure 10. Global Hormonal Drugs Sales YoY Growth (2016-2021) & (MT) Figure 11. Global Anticancer Drugs Sales by Type (2016-2027) & (US$ Million) Figure 12. Global Anticancer Drugs Sales Market Share in Volume by Type (2016-2021) Figure 13. Global Anticancer Drugs Sales Market Share in Value by Type (2016-2021) Figure 14. Global Anticancer Drugs Sales Market Share in Volume by Type (2022-2027) Figure 15. Global Anticancer Drugs Sales Market Share in Value by Type (2022-2027) Figure 16. North America Anticancer Drugs Sales Market Share in Volume by Type in 2020 Figure 17. North America Anticancer Drugs Sales Market Share in Value by Type in 2020 Figure 18. Europe Anticancer Drugs Sales Market Share in Volume by Type in 2020 Figure 19. Europe Anticancer Drugs Sales Market Share in Value by Type in 2020 Figure 20. Asia-Pacific Anticancer Drugs Sales Market Share in Volume by Type in 2020 Figure 21. Asia-Pacific Anticancer Drugs Sales Market Share in Value by Type in 2020 Figure 22. Latin America Anticancer Drugs Sales Market Share in Volume by Type in 2020 Figure 23. Latin America Anticancer Drugs Sales Market Share in Value by Type in 2020 Figure 24. Middle East and Africa Anticancer Drugs Sales Market Share in Volume by Type in 2020 Figure 25. Middle East and Africa Anticancer Drugs Sales Market Share in Value by Type in 2020 Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Anticancer Drugs Sales in 2020 Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Anticancer Drugs Revenue in 2020 Figure 28. Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Product Picture of Lung Cancer Figure 30. Global Lung Cancer Sales YoY Growth (2016-2027) & (MT) Figure 31. Product Picture of Breast Cancer Figure 32. Global Breast Cancer Sales YoY Growth (2016-2027) & (MT) Figure 33. Product Picture of Leukemia Figure 34. Global Leukemia Sales YoY Growth (2016-2027) & (MT) Figure 35. Product Picture of Colorectal Cancer Figure 36. Global Colorectal Cancer Sales YoY Growth (2016-2027) & (MT) Figure 37. Product Picture of Other Figure 38. Global Other Sales YoY Growth (2016-2027) & (MT) Figure 39. Global Anticancer Drugs Sales by Application (2016-2027) & (US$ Million) Figure 40. Global Anticancer Drugs Sales Market Share in Volume by Application (2016-2021) Figure 41. Global Anticancer Drugs Sales Market Share in Value by Application (2016-2021) Figure 42. Global Anticancer Drugs Sales Market Share in Volume by Application (2022-2027) Figure 43. North America Anticancer Drugs Sales Market Share in Volume by Application in 2020 Figure 44. Latin America Anticancer Drugs Sales Market Share in Value by Application in 2020 Figure 45. Middle East and Africa Anticancer Drugs Sales Market Share in Value by Application in 2020 Figure 46. Key Raw Materials Price Figure 47. Anticancer Drugs Manufacturing Cost Structure Figure 48. Anticancer Drugs Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed